The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
10 08 2019
Historique:
received: 15 06 2019
revised: 17 07 2019
accepted: 06 08 2019
entrez: 14 8 2019
pubmed: 14 8 2019
medline: 12 5 2020
Statut: epublish

Résumé

Patients with long-term, treated, rheumatoid arthritis (RA) show abnormalities in their circulating CD4+ T-lymphocytes, but whether this occurs in recently diagnosed naïve patients to disease-modifying drugs (DMARDs) is under discussion. These patients show heterogeneous clinical response to methotrexate (MTX) treatment. We have examined the count of circulating CD4+ T-lymphocytes, and their naïve (T

Identifiants

pubmed: 31405169
pii: cells8080871
doi: 10.3390/cells8080871
pmc: PMC6721760
pii:
doi:

Substances chimiques

Antirheumatic Agents 0
Methotrexate YL5FZ2Y5U1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Rheum Dis. 1994 Sep;53(9):580-6
pubmed: 7979596
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
J Rheumatol. 2016 Feb;43(2):282-8
pubmed: 26773113
Arch Immunol Ther Exp (Warsz). 2000;48(5):429-35
pubmed: 11140470
Arthritis Rheum. 1996 Jan;39(1):34-40
pubmed: 8546736
Eur J Immunol. 2009 Aug;39(8):2076-82
pubmed: 19672903
Nat Rev Immunol. 2012 Feb 17;12(3):191-200
pubmed: 22343568
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S58-64
pubmed: 21044435
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9203-8
pubmed: 10922071
Curr Protoc Cytom. 2002 Dec;Chapter 1:Unit 1.14
pubmed: 18770762
Methods Cell Biol. 2004;75:241-56
pubmed: 15603429
Rheumatology (Oxford). 2009 Sep;48(9):1021-8
pubmed: 19483089
Blood. 1998 Apr 1;91(7):2588-600
pubmed: 9516161
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
J Transl Med. 2015 Jan 16;13:2
pubmed: 25592233
Scand J Immunol. 1993 Jul;38(1):102-12
pubmed: 8392222
Genes Immun. 2005 May;6(3):248-61
pubmed: 15674392
Immunobiology. 1993 Aug;188(4-5):330-9
pubmed: 8244441
Ann Rheum Dis. 1993 May;52(5):327-31
pubmed: 8323379
Arthritis Rheum. 1995 Oct;38(10):1429-46
pubmed: 7575693
Clin Immunol Immunopathol. 1993 Jul;68(1):79-87
pubmed: 8513596
Eur J Immunol. 1992 May;22(5):1261-9
pubmed: 1533591
Clin Exp Immunol. 2011 Feb;163(2):157-64
pubmed: 21155991
Arthritis Rheum. 1996 May;39(5):844-54
pubmed: 8639182
Blood. 1996 Apr 1;87(7):3032-44
pubmed: 8639927
Rheumatol Int. 1996;16(2):77-87
pubmed: 8853229
BioDrugs. 2009;23(2):111-24
pubmed: 19489652
Ann Rheum Dis. 2016 Feb;75(2):459-65
pubmed: 25498120
J Clin Rheumatol. 2005 Jun;11(3 Suppl):S39-44
pubmed: 16357749
Trends Immunol. 2009 Jul;30(7):306-12
pubmed: 19540809
Scand J Clin Lab Invest Suppl. 1968;97:77-89
pubmed: 4179068
Exp Gerontol. 2003 Nov-Dec;38(11-12):1243-9
pubmed: 14698803
Lancet. 2010 Sep 25;376(9746):1094-108
pubmed: 20870100
Clin Immunol. 2018 Dec 10;:
pubmed: 30543918
J Autoimmun. 1993 Oct;6(5):621-37
pubmed: 8240665
Int Immunol. 2008 Sep;20(9):1189-99
pubmed: 18635582
Cytometry A. 2008 Nov;73(11):975-83
pubmed: 18785267
Int Rev Immunol. 1998;17(5-6):339-63
pubmed: 10036639
Blood. 2002 Dec 15;100(13):4550-6
pubmed: 12393721
Ann Rheum Dis. 2019 Aug;78(8):1070-1078
pubmed: 31101603
Rheum Dis Clin North Am. 2010 May;36(2):297-310
pubmed: 20510235
J Clin Invest. 1996 May 1;97(9):2027-37
pubmed: 8621791
Curr Opin Immunol. 2011 Jun;23(3):319-23
pubmed: 21524898
Front Immunol. 2013 May 10;4:107
pubmed: 23675374
Blood. 1998 Jun 1;91(11):4224-31
pubmed: 9596670
Ann Rheum Dis. 2012 Jun;71(6):1088-93
pubmed: 22294635
Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v3-11
pubmed: 22718924
Arthritis Res Ther. 2008;10 Suppl 1:S1
pubmed: 19007421
Immunol Rev. 2005 Apr;204:55-73
pubmed: 15790350
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Exp Gerontol. 2007 May;42(5):400-6
pubmed: 17218073
FEBS Lett. 2011 Dec 1;585(23):3649-59
pubmed: 21515267
Arthritis Rheum. 1994 Oct;37(10):1431-40
pubmed: 7945467
J Immunoassay Immunochem. 2014;35(2):207-19
pubmed: 24295183
Arthritis Res Ther. 2012 Jul 27;14(4):R175
pubmed: 22838733
Ann N Y Acad Sci. 2005 Dec;1062:182-94
pubmed: 16461801
J Autoimmun. 2007 Sep-Nov;29(2-3):154-63
pubmed: 17826949
Curr Top Microbiol Immunol. 2006;305:195-211
pubmed: 16724807
J Immunol. 1994 May 15;152(10):5109-19
pubmed: 8176227
J Immunol. 1998 Oct 15;161(8):4428-36
pubmed: 9780222
Ann Rheum Dis. 2006 Aug;65(8):990-7
pubmed: 16414969
Ann Rheum Dis. 1998 May;57(5):319-22
pubmed: 9741318
Ann Rheum Dis. 2014 Mar;73(3):492-509
pubmed: 24161836
Nat Rev Immunol. 2002 Apr;2(4):251-62
pubmed: 12001996
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Rheumatol Int. 1996;15(5):201-9
pubmed: 8717104
Annu Rev Immunol. 2004;22:745-63
pubmed: 15032595
Clin Immunol. 2001 May;99(2):253-65
pubmed: 11318597
Clin Rheumatol. 2019 Jul;38(7):1831-1839
pubmed: 30809737

Auteurs

Jorge Monserrat (J)

Laboratory of Immune System Diseases, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.

Cristina Bohórquez (C)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Ana María Gómez Lahoz (AM)

Laboratory of Immune System Diseases, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Atusa Movasat (A)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Ana Pérez (A)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Lucía Ruíz (L)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

David Díaz (D)

Laboratory of Immune System Diseases, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Luis Chara (L)

Laboratory of Immune System Diseases, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Ana Isabel Sánchez (AI)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Fernando Albarrán (F)

Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain.

Ignacio Sanz (I)

Division of Immunology and Rheumatology, Department of Medicine, Emory University, Atlanta, GA 30322, USA.

Melchor Álvarez-Mon (M)

Laboratory of Immune System Diseases, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain. mademons@gmail.com.
Department of Medicine, University Hospital "Príncipe de Asturias", University of Alcalá and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Alcalá de Henares, 28871 Madrid, Spain. mademons@gmail.com.
Immune System Diseases-Rheumatology Service, University Hospital "Príncipe de Asturias", Alcalá de Henares, 28871 Madrid, Spain. mademons@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH